ELDN
Eledon Pharmaceuticals, Inc.
3.88
8 x 2.83
1 x 4.97
bid
ask
-
0.02
0.38%
11:24 AM
timesize
| Ytd | 157.28% | |
| 1y | 26.96% |
3.88
day range
3.99
1.35
52 week range
4.60
| Open | 3.95 | Prev Close | 3.90 | Low | 3.88 | High | 3.99 | Mkt Cap | 299.10M |
| Vol | 341.01K | Avg Vol | 1.53M | EPS | -0.77 | P/E | N/A | Forward P/E | -3.49 |
| Beta | 0.77 | Short Ratio | 0.75 | Inst. Own | 42.88% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 3.72 | 200-d Avg | 2.78 | 1yr Est | 12.50 |
| Income Statement | |||
| Operating Expenses | 21.18M | ||
| Research and Development Expense | 17.20M | ||
| Selling, General and Administrative Expense | 3.98M | ||
| Operating Income | -21.18M | ||
| Net Income | -39.02M | ||
| Net Income Common Stock | -39.02M | ||
| Net Income Common Stock (USD) | -39.02M | ||
| Consolidated Income | -39.02M | ||
| Earnings per Basic Share | -0.33 | ||
| Earnings per Basic Share (USD) | -0.33 | ||
| Earnings per Diluted Share | -0.33 | ||
| Earning Before Interest & Taxes (EBIT) | -39.02M | ||
| Earning Before Interest & Taxes (USD) | -39.02M | ||
| Weighted Average Shares | 112.42M | ||
| Weighted Average Shares Diluted | 112.42M | ||
| Balance Sheet | |||
| Cash and Equivalents | 6.15M | ||
| Cash and Equivalents (USD) | 6.15M | ||
| Investments | 104.94M | ||
| Investments Current | 104.94M | ||
| Current Assets | 113.57M | ||
| Property, Plant & Equipment Net | 530.00K | ||
| Total Assets | 146.67M | ||
| Debt Current | 369.00K | ||
| Total Debt | 555.00K | ||
| Current Liabilities | 13.46M | ||
| Debt Non-Current | 186.00K | ||
| Total Liabilities | 46.21M | ||
| Accumulated Retained Earnings (Deficit) | -440.23M | ||
| Accumulated Other Comprehensive Income | -72.00K | ||
| Shareholders Equity | 44.76M | ||
| Shareholders Equity (USD) | 44.76M | ||
| Assets Non-Current | 33.09M | ||
| Total Debt (USD) | 555.00K | ||
| Liabilities Non-Current | 32.75M | ||
| Trade and Non-Trade Payables | 6.59M | ||
| Tax Liabilities | 2.19M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 83.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -16.66M | ||
| Net Cash Flow from Investing | 5.96M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 5.96M | ||
| Net Cash Flow from Operations | -22.61M | ||
| Share Based Compensation | 2.20M | ||